Quest Diagnostics Inc (NYSE:DGX)
| 132.51 BATS BZX Real-Time Price As of 1:18pm ET |  +2.49 / +1.92%Today’s Change | 95.52 Today|||52-Week Range 134.71 | +11.19% Year-to-Date |
Latest DGX News | Press Releases
| Quest Diagnostics (DGX) Q1 Earnings Miss, Base Recovery Strong 9:28am / Zacks.com - Paid Partner Content | Molecular Tests to Drive Quest Diagnostics (DGX) Q1 Earnings Apr 19 / Zacks.com - Paid Partner Content |
| Quest Diagnostics (DGX) Q1 Earnings Lag Estimates 8:05am / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 130.02 |
| Today’s open | 130.66 |
| Day’s range | 128.64 - 133.75 |
| Volume | 1,198,185 |
| Average volume (3 months) | 1,290,890 |
| Market cap | $17.1B |
Data as of 1:18pm ET, 04/22/2021
Growth & Valuation
| Earnings growth (last year) | +67.37% |
| Earnings growth (this year) | -1.58% |
| Earnings growth (next 5 years) | -1.10% |
| Revenue growth (last year) | +22.15% |
| P/E ratio | 12.8 |
| Price/Sales | 1.72 |
| Price/Book | 2.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GHGuardant Health Inc | +3.83 | +2.51% |
| NTRANatera Inc | -1.50 | -1.37% |
| LHLaboratory Corporati... | +1.98 | +0.76% |
| NVTAInvitae Corp | +0.10 | +0.28% |
Data as of 1:19pm ET, 04/22/2021
Financials
| Last reporting date | April 22, 2021 |
| EPS forecast (this quarter) | $3.71 |
| Annual revenue (last year) | $9.4B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 15.10% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Secaucus, New Jersey |
Forecasts
